Cart (Loading....) | Create Account
Close category search window
 

In vitro immunoisolative properties of microfabricated biocapsules

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

4 Author(s)
Desai, T.A. ; Bioeng. Graduate Group, California Univ., Berkeley, CA, USA ; Ferrari, M. ; Cheung, K. ; Wen Hwa Chu

Transplantation of cells with specific functions is a promising therapy for a wide variety of diseases including diabetes, Parkinson's, and hemophilia. Such transplanted cells, however, are sensitive to both cellular and humoral immune rejection as well as damage by autoimmune activity, without chronic immunosuppression. This study investigates whether microfabricated silicon-based biocapsules, with uniform membrane pore sizes in the tens of nanometer range, can provide immunoprotection of transplanted cells by blocking the passage of IgG through the biocapsule. By utilizing microfabrication technology, biocapsules can be fabricated with membranes having precisely controlled and uniform pore sizes, allowing one to optimize parameters specifically for the encapsulation of specific hormone-secreting cell types. The permeability of IgG was studied in microfabricated biocapsules with various pore sized membranes. In addition, immunoisolative characteristics were monitored by assessing viability and functionality of islets within biocapsules. The semipermeability of microfabricated biocapsules, along with their stability and biocompatibility, may provide an improved encapsulation device for immunoisolation of cell xenografts for hormone therapy, i.e. production of insulin by pancreatic islets in response to changing glucose levels

Published in:

Engineering in Medicine and Biology Society, 1997. Proceedings of the 19th Annual International Conference of the IEEE  (Volume:6 )

Date of Conference:

30 Oct-2 Nov 1997

Need Help?


IEEE Advancing Technology for Humanity About IEEE Xplore | Contact | Help | Terms of Use | Nondiscrimination Policy | Site Map | Privacy & Opting Out of Cookies

A not-for-profit organization, IEEE is the world's largest professional association for the advancement of technology.
© Copyright 2014 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.